mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.01 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.01 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.096 |
0.02 |
mRNA |
salermide |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.02 |
mRNA |
PHA-665752 |
CCLE |
pan-cancer |
AAC |
0.13 |
0.02 |
mRNA |
AEW541 |
CCLE |
pan-cancer |
AAC |
0.12 |
0.02 |
mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.02 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.086 |
0.02 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
0.13 |
0.02 |